SeekingAlpha · Nov 12, 2026
Novanta: The Selloff Still Leaves Little Room For Error
Novanta is a Hold as current valuation offers limited upside despite operational improvements and growth catalysts. Read more on NOVT stock here.
NASDAQ · NOVT
Technology · Hardware, Equipment & Parts
$114.88
Down-$3.01 (-2.55%)
Updated Nov 20, 2026, 1:08 PM
SID Score
4.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance · NOVT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
NOVT closed at $114.88 after 21 trading sessions, down 15.94% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $119.995 | $120.805 | $114.375 | $114.88 | 455.11K |
| Nov 18, 2026 | $114.56 | $118.9525 | $113.16 | $117.89 | 456.31K |
| Nov 17, 2026 | $115.38 | $115.755 | $111.985 | $115.33 | 668.54K |
| Nov 16, 2026 | $115.12 | $116.84 | $113.26 | $114.40 | 679.72K |
| Nov 13, 2026 | $118.13 | $121.44 | $113.13 | $118.88 | 606.61K |
| Nov 12, 2026 | $118.96 | $121.11 | $114.84 | $117.42 | 877.7K |
| Nov 11, 2026 | $128.125 | $130.36 | $123.065 | $123.31 | 1.19M |
| Nov 10, 2026 | $134.00 | $134.00 | $120.01 | $123.71 | 1.56M |
| Nov 9, 2026 | $138.42 | $147.36 | $136.45 | $145.98 | 410.02K |
| Nov 6, 2026 | $134.48 | $135.385 | $132.24 | $135.15 | 468.7K |
| Nov 5, 2026 | $142.195 | $142.37 | $130.285 | $131.82 | 474K |
| Nov 4, 2026 | $150.08 | $150.08 | $140.30 | $145.23 | 396.49K |
| Nov 3, 2026 | $148.28 | $150.54 | $146.99 | $147.49 | 373.19K |
| Nov 2, 2026 | $149.17 | $151.68 | $145.00 | $146.24 | 395.11K |
| Oct 30, 2026 | $145.83 | $149.83 | $143.6025 | $145.76 | 421.17K |
| Oct 29, 2026 | $149.53 | $154.15 | $149.065 | $151.18 | 390.6K |
| Oct 28, 2026 | $151.21 | $153.32 | $149.325 | $150.66 | 329.95K |
| Oct 27, 2026 | $147.01 | $150.00 | $144.71 | $149.35 | 302.55K |
| Oct 26, 2026 | $141.33 | $146.33 | $141.29 | $144.02 | 373.9K |
| Oct 23, 2026 | $135.22 | $141.2791 | $132.195 | $140.80 | 392.81K |
| Oct 22, 2026 | $135.70 | $137.05 | $133.00 | $136.66 | 394.22K |
The latest Smart Investors Daily articles mentioning NOVT.
Company
Market Activity
Research & News
NOVT research
Company profile and research snapshot.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 12, 2026 | Baird | Outperform | — |
| May 13, 2026 | Baird | Outperform | — |
| Mar 30, 2026 | Baird | Outperform | — |
| Aug 11, 2025 | Baird | Neutral | — |
| Mar 3, 2025 | Baird | Neutral | — |
No generated briefing is available yet.
SeekingAlpha · Nov 12, 2026
Novanta is a Hold as current valuation offers limited upside despite operational improvements and growth catalysts. Read more on NOVT stock here.
Benzinga · Nov 12, 2026
Baird analyst Quinn Fredrickson maintains Novanta (NASDAQ:NOVT) with a Outperform and lowers the price target from $194 to $175.
SeekingAlpha · Nov 10, 2026
Novanta Inc. (NOVT) Q3 2026 Earnings Call November 10, 2026 8:00 AM ESTCompany ParticipantsMarcella MeditzMatthijs Glastra - CEO & Chairman of the...
Benzinga · Nov 9, 2026
Novanta (NASDAQ:NOVT) lowers FY2026 Adj EPS guidance from $3.68-$3.74 to $3.66-$3.71 vs $3.69 analyst estimate. Raises FY2026 sales outlook from $1.130 billion-$1.140 billion to $1.135 billion-$1.140 billion vs $1.134
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NOVT.